Associations between change in C-reactive protein and serum lipids during statin treatment

Annals of Medicine

Volumn 32, Issue 8, 2000, Pages 579-583

  Strandberg, T E ^a   Vanhanen, H ^a   Tikkanen, M J ^a  

^a Haartmaninkatu   (Finland)

Author keywords

Atorvastatin; C reactive protein; High density lipoprotein cholesterol; Simvastatin

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; STATIN;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPOLIPEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME;

EID: 0033646611     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853890008998838     Document Type: Article

References (16)

1. Effect of statin treatment on C-reactive protein in coronary patients
2. Inflammation markers and coronary heart disease
3. Novel inflammatory markers of coronary risk. Theory versus practice
4. Statins and C-reactive protein
5. Long-term effects of pravastatin on plasma concentration of C-reactive protein
6. Statins and C-reactive protein
7. Statins and blockers of the reninangiotensin system. Vascular protection beyond their primary mode of action
8. Non-lipid-related effects of statins
9. Immunoturbidimetric determination of apolipoproteins A-1 and B in serum
10. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women
11. C-reactive protein, sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men
12. Insulin resistance and inflammation in an evolutionary perspective: The contribution of cytokine genotype/phenotype to thriftiness
13. Anti-inflammatory effects of re-constituted high-density lipoprotein during human endotoxemia
14. Cytokines decrease apolipo-protein accumulation in medium from Hep G2 cells
15. HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia
16. Coronary C-reactive protein distribution: Its relation to development of atherosclerosis